PROTECT: Prospective Phase-II-Trial Evaluating Adaptive Proton Therapy for Cervical Cancer to Reduce the Impact on Morbidity and the Immune System.
Corbeau A, Nout RA, Mens JWM, Horeweg N, Godart J, Kerkhof EM, Kuipers SC, van Poelgeest MIE, Kroep JR, Boere IA, van Doorn HC, Hoogeman MS, van der Heide UA, Putter H, Welters MJP, van der Burg SH, Creutzberg CL, de Boer SM.
Corbeau A, et al. Among authors: kuipers sc.
Cancers (Basel). 2021 Oct 15;13(20):5179. doi: 10.3390/cancers13205179.
Cancers (Basel). 2021.
PMID: 34680328
Free PMC article.